Potassium ion (K ϩ ) channels provide a K ϩ -selective aqueous pore for the diffusion of K ϩ across the plasma membrane and are essential for the function of most, if not all, mammalian cell types. Voltage-gated potassium (K v ) channels are gated (opened and closed) by changes in membrane potential. They are opened by membrane depolarization and are essential for the timely repolarization of excitable cells. Other K ϩ channels are constitutively active, that is, open at resting membrane potential. Defining the role of constitutively active K ϩ channels in vivo can be challenging: they contribute an often temporally invariant "background" K ϩ conductance and may be expressed in cell types resistant to faithful primary culturing or direct electrophysiological analysis. In addition, constitutively active K ϩ channels, in particular, may be important for processes difficult to quantify in vivo or in vitro, including ion homeostasis and hormone synthesis and release.
The KCNQ1-KCNE2 potassium channel has an unusual molecular composition for a constitutively active K ϩ channel but is widely studied because its subunits are required for a range of processes essential in human physiology. The KCNQ1 pore-forming (␣) subunit contains the S4-based voltage-sensing domain present in voltage-gated K ϩ , Na ϩ , and Ca 2ϩ channels. However, although homomeric channels formed by a tetramer of KCNQ1 ␣ subunits are voltage-gated, heteromeric channel complexes comprising KCNQ1 together with the single-transmembrane segment KCNE2 ␤ subunit are constitutively active, and relatively voltage-insensitive (1). KCNQ1-KCNE2 channels are essential for the physiology of at least two types of nonexcitable, polarized epithelial cells: gastric parietal cells, which secrete gastric acid, and thyroid epithelial cells, which secrete thyroid hormones. Targeted deletion of either Kcnq1 or Kcne2 causes both hypothyroid-ism and achlorhydria, demonstrating the absolute necessity for both ␣ and ␤ subunits in the native channel complex (2) (3) (4) (5) (6) . Kcne2 Ϫ/Ϫ mice also exhibit dwarfism, alopecia (Fig. 1A) , prenatal mortality, and cardiomegaly, all of which arise from their underlying hypothyroidism (5) . Human KCNQ1 and KCNE2 gene mutations cause potentially fatal ventricular and atrial cardiac arrhythmias, probably primarily due to the role of these subunits in cardiac myocyte K ϩ currents (7, 8) ; however, the discovery of the KCNQ1-KCNE2 channel in mouse and human thyroid suggests a possible endocrine component to these electrical disturbances (5) . Here, we sought to elucidate the mechanistic basis for the requirement for KCNQ1-KCNE2 channels in thyroid function. To examine thyroid physiology in vivo, we utilized positron emission tomography (PET), which facilitated real-time quantification of 124 I Ϫ fluxes in vivo, in mice genetically and pharmacologically manipulated to isolate different steps in thyroid hormone biosynthesis. We demonstrate that KCNQ1-KCNE2 is required for Na ϩ /I Ϫ symporter (NIS)-mediated thyroid cell uptake of I Ϫ , an essential step in thyroid hormone biosynthesis.
MATERIALS AND METHODS

Transgenic mouse generation, care, and use
We generated and genotyped the C57BL/6 Kcne2 Ϫ/Ϫ mouse line, as described previously (4, 5) and housed and used mice, according to the U.S. National Institutes of Health Guide for the Care and Use of Laboratory Animals. Animal procedures were approved by the Animal Care and Use Committees at Weill Medical College of Cornell University and Albert Einstein College of Medicine.
PET and computed tomography (CT)
Mice were secured to a bed with a breathing tube over their snout that provided a continuous supply of isoflurane anesthetic throughout the imaging procedure (Fig. 1C) . Imaging was performed on an Inveon Multimodality scanner (Siemens, Munich, Germany), in which CT X-rays were generated by an 80-kV peak voltage difference between cathode and tungsten target at 0.5-mA current and 250-ms exposure time. The CT field of view was 5.5 by 8.5 cm, with an overall resolution without magnification of 100 m. Subsequent PET imaging was performed by translating the test subject on the imaging gantry into the PET device, which provided a 12.7-cm axial and 10-cm transaxial active field of view. The PET scanner has no septa, and acquisitions were performed in 3-dimensional (3D) list mode. A reconstructed full-width half-maximum resolution of Ͻ1.4 mm is achievable in the center of the axial field of view. List mode acquisition of data was performed to permit dynamic reframing for kinetic evaluation of 124 I Ϫ uptake, where indicated. After each acquisition, data were sorted into 3D sinograms, and images were reconstructed using a 2-dimensional (2D)-ordered subset expectation maximization algorithm. Data were corrected for deadtime counting losses, random coincidences, and the measured nonuniformity of detector response (i.e., normalized), but not for attenuation or scatter. After both acquisitions, CT images were coregistered with PET images using a previously stored linear transformation matrix.
Analysis was performed using ASIPRO (Siemens) dedicated software. All image studies were inspected visually in a rotating 3D projection display to examine for interpretability and image artifact. Manual regions of interest (ROIs) were defined around the thyroid. Successive scrolling through 2D slices (each 1.2 mm thick in the axial images) permitted measurement of a radioactivity within defined volumes and also as profiles in reconstructed image planes. The counts per cubic centimeter within this volume multiplied by the 3D ROI volume after correction for detector sensitivity, animal weight, and time of injection determined the standardizeduptake value (SUV). For quantitative comparisons of I Ϫ efflux rates in vivo during ClO 4 Ϫ discharge, we fitted SUV decay over time with a single exponential function and reported the rate as . For quantitative comparison of I Ϫ uptake, we subjected initial (linear) portion of individual uptake plots (0 -13.3 min) to linear regression analysis, and we report the slope as mean dSUV/dt, as described previously (9) .
Methimazole (MMI) treatment
Mice were given an intraperitoneal injection of 1 mg MMI (Sigma-Aldrich, St. Louis, MO, USA) in 100 l total volume filter-sterilized PBS, and overnight ad libitum access to drinking water containing 250 g/ml MMI.
Perchlorate discharge assay
Lactating dams, anesthetized with 1.5% isoflurane-oxygen mixture, received 200 -300 Ci (7) (8) (9) (10) (11) (12) 124 I Ϫ in 0.1 ml saline solution via tail-vein injection. Dams were placed back in their cages for 90 min to allow accumulation of the 124 I Ϫ tracer in the thyroid, then imaged for 10 min before, and for the 60 min following, injection of 2-mg sodium perchlorate (NaClO 4 ; Sigma Aldrich) in a total volume of 0.1 ml PBS via tail vein. Measurements of thyroid counts taken at 5-min intervals following NaClO 4 injection were normalized to the maximum count value taken from the pre-ClO 4 Ϫ image.
Uptake experiments
Stock solutions of 80 mM (Ϫ)-[3R,4S]-chromanol 293B
(C293B; Tocris Biosciences, Cambridge, UK) dissolved in pure DMSO were prepared and stored at Ϫ20°C. The stock was diluted to a final concentration of 2.5 mg/ml in PBS with 20% DMSO. Vehicle controls contained 20% DMSO in PBS. Mice were injected with 0.1 ml of drug or vehicle 30 min before injection with 124 I Ϫ (150 Ci, 5.55 MBq) dissolved in 0.1 ml saline.
Cell culture, transport, and flow cytometry experiments
FRTL-5 cells were grown in Coon's modified Ham's F12 medium supplemented with 5% newborn calf serum (Sigma Aldrich) and 6 different hormones (10 mg/ml insulin 5 mg/ml , transferrin, 10 nM hydrocortisone, 10 nt/ml tripeptide Gly-L-His-L-Lys, 0.3 mU/ml TSH, and 10 ng/ml somatostatin) in a water-saturated atmosphere of 5% CO 2 COS-7 cells were grown in DMEM supplemented with 10% heat-inactivated FBS (Sigma-Aldrich). Cells were transfected with 10 g/10-cm dish pcDNA3.1-rNIS or -hNIS cDNA constructs using polyethylenimine. I Ϫ uptake activity was assayed at 48 h post-transfection.
RESULTS
PET imaging of a chemically induced iodine organification defect in mouse thyroid
We previously utilized PET imaging to discover that Kcne2 deletion in mice impairs thyroid 124 I Ϫ accumulation (5). Here, we combined PET with other techniques to determine the underlying mechanism for this impairment. Thyrocytes actively take up I Ϫ via NIS at the basolateral surface (12) . I Ϫ next effluxes across the thyrocyte apical membrane to the cell-colloid interface, where it is oxidized and covalently incorporated into specific tyrosyl residues on thyroglobulin (Tg; Fig.   3254 Vol. 26 August 2012
PURTELL ET AL. The FASEB Journal ⅐ www.fasebj.org 1B)-a process termed "organification" and catalyzed by thyroid peroxidase (TPO) and the NADPH-dependent H 2 O 2 -generating system (Duox). Iodinated Tg is then stored in the colloid until demand for thyroid hormones causes Tg to be apically endocytosed and proteolyzed, and thyroid hormones to be basolaterally secreted into the bloodstream (13, 14) . To establish the mechanism for impaired thyroid I Ϫ accumulation in Kcne2 Ϫ/Ϫ mice, we needed to distinguish between free I Ϫ and iodine covalently incorporated into Tg, and also between I Ϫ uptake and iodine organification, both of which determine thyroid I -accumulation. First, we employed coregistered PET and X-ray CT on mice tail-vein-injected with 124 I, to confirm positioning of the thyroid signal compared to other I Ϫ -accumulating tissues, such as the stomach and bladder (Fig.  1C) . We then sought to determine whether KCNQ1-KCNE2 is required for thyroid I Ϫ organification, using PET in combination with the well-established perchlorate (ClO 4 Ϫ ) discharge assay (PDA). ClO 4 Ϫ , a competitive inhibitor of NIS that is translocated electroneutrally (15) , causes a rapid reduction of free I Ϫ in the thyroid (as I Ϫ can efflux from but not enter the thyrocyte in its presence). When organification is normal, ClO 4 Ϫ elicits only moderate thyroid I Ϫ discharge (ϳ15%) because most I Ϫ is rapidly covalently bound to Tg, whereas an organification defect can result in a ClO 4 Ϫ -induced I Ϫ discharge of 50% or more (16) . We first assessed the suitability of PET for quantifying ClO 4 Ϫ discharge in the mouse thyroid, by ascertaining the effect of pretreating wild-type C57BL/6 mice with MMI, a thionamide that blocks I Ϫ organification by inhibiting TPO (17, 18) . MMI pretreatment involved an intraperitoneal injection of MMI, followed by overnight ad libitum access to water supplemented with MMI. The following day, 90 min after tail-vein injection of 124 I Ϫ , a 10-min static PET image was generated to measure peak 124 I Ϫ accumulation. Mice immediately received ClO 4 Ϫ via tail-vein injection and were PET imaged dynamically at 5-min intervals for 60 min (Fig.  1D, E) . Mean thyroid radioactivity at each 5-min interval following ClO 4 Ϫ injection was normalized to the mean pre-ClO 4 Ϫ thyroid radioactivity to quantify discharge. ClO 4 Ϫ resulted in a 45 Ϯ 4% discharge of 124 I within the first hour after injection in MMI-pretreated mice, thereby confirming successful detection of the chemically induced organification defect and validating the PET assay (nϭ5; Fig. 1F ).
KCNQ1-KCNE2 is not required for I ؊ organification
We next quantified the effect of targeted deletion of Kcne2 on ClO 4 Ϫ -induced discharge of thyroid I Ϫ in non-MMI-treated lactating C57BL/6 mice using PET, following the protocol outlined in Fig. 2A , and observed 19 Ϯ 3% discharge within the first hour after injection in Kcne2 ϩ/ϩ mice, compared to 14 Ϯ 4% in Kcne2 Ϫ/Ϫ mice (nϭ5; Pϭ0.19; Fig. 2B, C) . There was, therefore, no significant effect of Kcne2 deletion on organification. Furthermore, both non-MMI-pretreated groups exhibited significantly less I -discharge than MMI-pretreated Kcne2 ϩ/ϩ mice (nϭ5; PϽ0.0005; Fig.  2C ). Interestingly, while the extent of I Ϫ efflux following ClO 4 Ϫ injection appeared Kcne2-independent, fitting the discharge plots from individual mice with a single exponential function indicated a trend (Pϭ0.17) toward increased rate of I Ϫ efflux in Kcne2 Ϫ/Ϫ mice (ϭ284Ϯ117 ms; nϭ5) compared to their Kcne2 ϩ/ϩ counterparts (712Ϯ366 ms; nϭ4). Lactating mice were used for these experiments because hypothyroidism in Kcne2 Ϫ/Ϫ mice is most marked during early development, gestation, lactation, and in old age (5).
KCNQ1-KCNE2 is required for efficient I
؊ uptake
The absence of an organification defect in Kcne2
mice, combined with our previous finding that Kcne2 deletion impairs thyroid I Ϫ accumulation (5), suggested KCNQ1-KCNE2 could be important for NISmediated I Ϫ uptake. To test this hypothesis, we first used the highly specific KCNQ1 antagonist (Ϫ)-[3R,4S]-chromanol 293B (C293B) to acutely inhibit KCNQ1-KCNE2, in Kcne2 ϩ/ϩ mice pretreated with MMI to inhibit organification, allowing us to assess I (Fig. 3A) . Strikingly, C293B (10 mg/kg) impaired 124 I Ϫ by 42% at 60 min, giving a mean thyroid radioactivity of 0.69 Ϯ 0.11 SUV (i.e., counts normalized to whole-body mean radioactivity concentration; whole-body SUVϭ1.00, by definition) compared to 1.18 Ϯ 0.06 SUV in vehicle-injected mice (nϭ5; PϽ0.005; Fig. 3B, C) , signifying inhibition of 124 I uptake and retention. Initial thyroid I Ϫ uptake rates were reduced 3-fold by C293B (10 mg/kg), with the dSUV/dt being reduced from 0.028 Ϯ 0.004 min
Ϫ1
(vehicle) to 0.009 Ϯ 0.006 min Ϫ1 (C293B; nϭ5, Pϭ 0.014; Fig. 3D ).
To validate this finding in an alternative system, we performed 125 I Ϫ flux assays using the highly functional rat thyroid-derived FRTL-5 nonpolarized cell line (Fig. 4A) , which we previously showed expresses KCNQ1-KCNE2 channel protein and K ϩ current (5). FRTL-5 cells exhibit minimal I Ϫ organification, but express NIS and efficiently transport I Ϫ . Increasing concentrations of C293B inhibited NIS-mediated I Ϫ uptake in a dose-dependent manner (EC 50 : 99Ϯ10 M C293B; nϭ4; Fig. 4B ); in contrast, they did not affect another Na ϩ -driven transport process, namely SMCTmediated nicotinate uptake (Fig. 4B) , demonstrating the specificity of the inhibition of I Ϫ uptake and also indicating that impaired NIS function arising from KCNQ1-KCNE2 inhibition does not stem from a dis- rupted Na ϩ gradient. In support of the KCNQ1-dependence of action of C293B, it did not inhibit cell-surface expression of HA-tagged NIS in FRTL-5 cells, as quantified by flow cytometry, indicating that the decrease of I Ϫ uptake caused by C293B is not due to fewer NIS molecules at the plasma membrane (Fig. 4C) . Likewise, C293B had no effect on I Ϫ uptake through rat or human NIS when heterologously expressed, without KCNQ1 overexpression, in COS-7 cells (Fig. 4D) .
DISCUSSION
After initially being recognized for their respective roles in voltage-dependent K ϩ channels in cardiac myocytes, KCNQ1 and KCNE2 were found to form a constitutively active K ϩ channel (1), subsequently identified in gastric parietal cells (3, 19) . KCNQ1-KCNE2 recycles K ϩ from the parietal cell to the stomach lumen, facilitating the 1:1 exchange of H ϩ ions for K ϩ ions required by the H ϩ /K ϩ -ATPase for gastric acid secretion (3, 19, 20) . Thus, genetic disruption of either Kcnq1 or Kcne2 in mice causes achlorhydria and gastric hyperplasia owing to an inability to secrete gastric acid (2, 4) . Following up on our recent discovery that the KCNQ1-KCNE2 K ϩ channel is important for thyroid hormone biosynthesis (5), we have now used PET to uncover the mechanistic basis for this requirement: without functional KCNQ1-KCNE2, I
Ϫ uptake into the thyroid is impaired, with no direct effect on I Ϫ organification (Fig. 5) .
The requirement for KCNQ1-KCNE2 for thyroidal I Ϫ uptake may indicate that KCNQ1-KCNE2 is necessary for adequate function of NIS, the primary thyrocyte I Ϫ uptake conduit. This functional requirement almost certainly does not involve a need for KCNQ1-KCNE2 to supply the thyrocyte basolateral Na ϩ /K ϩ ATPase with K ϩ , so that it can maintain a Na ϩ gradient for NIS, because KCNQ1 inhibition did not affect function of another Na ϩ -driven transporter, SMCT (Fig. 4B) . One possible mechanism is that KCNQ1-KCNE2 is required to regulate thyrocyte membrane potential in vivo, and that with Kcne2 or Kcnq1 deleted, or the channel pharmacologically inhibited, this function is perturbed. NIS-mediated I Ϫ uptake is electrogenic, with 2 Na ϩ entering for every I Ϫ ; therefore, its activity would depolarize the cell in the absence of other regulatory ion fluxes. Given that KCNQ1-KCNE2 is constitutively active, it has the capacity to permit K ϩ efflux to help maintain a negative membrane potential. If this channel is pharmacologically blocked (Fig. 5B) , or if the Kcnq1 gene itself is deleted, the thyrocyte could become depolarized, and NIS function could, therefore, be impaired as a result of a decrease in the membrane potential, one of the two components of the electrochemical driving force of NIS.
Deletion of Kcne2 may have slightly different effects, albeit still resulting in impaired thyroid hormone biosynthesis. We recently found that KCNE2 is expressed in the choroid plexus epithelium, where it forms K 
